What is the MTNB stock price prediction for next 2 weeks?

According to our price prediction algorithm,Matinas BioPharma Holdings, Inc. (MTNB) price will be around $0.11 in the next 2 weeks. This means it will decrease by -53.06545153272576 from the last closing price. This prediction may vary from other time period filters for MTNB stock.

What can be the highest Possible price of MTNB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, MTNB can achieve the highest price of $0.22 which is -10.652530523978252 lower than last closing price. This prediction may vary from other time period filters for MTNB stock.

What can be the lowest Possible price of MTNB stock in next 2 weeks?

As per the forecast and algorithmic analysis, MTNB stock price can be as low as $0.02 which is -92.12294416267464 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for MTNB stock.

Will MTNB stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that MTNB stock will lose-53.06545153272576 in the next 2 weeks. This prediction may vary from other time period filters for MTNB stock.

What is MTNB stock last closing price?

Last closing price of MTNB stock was $0.34.

What is MTNB stock price prediction?

MTNB stock price prediction means predicting the future closing prices of MTNB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of MTNB stock in a certain time period.

How we predict MTNB stock future prices?

If you are searching for MTNB stock forecast, analysis or price prediction, then you might be wondering what Matinas BioPharma Holdings, Inc. (MTNB) will do in the future. Our MTNB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This MTNB price prediction will likely answer most of your questions.

How frequent we update MTNB stock predictions?

We are updating the forecasts for the MTNB stock on daily basis.

Is using ML forecasting for MTNB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for MTNB stock same for all the time periods?

No, the prediction for MTNB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Matinas BioPharma Holdings, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.34-29.4%Since 2 Weeks

Predicted Price$0.11-53.07%For 2 Weeks

Upper Predicted Price$0.22-10.65%For 2 Weeks

Lower Predicted Price$0.02-92.12%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of MTNB will decline by -53.07% over the next 2 Weeks and hit $0.11 by Friday, August 7, 2026. In that time frame, MTNB's share price is expected to range between $0.02 and $0.22.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Aug 7, 2026	0.00	0.09	0.19
Aug 6, 2026	0.00	0.06	0.15
Aug 5, 2026	0.00	0.08	0.18
Aug 4, 2026	0.00	0.08	0.19
Aug 3, 2026	0.02	0.12	0.21
Jul 31, 2026	0.07	0.17	0.27
Jul 30, 2026	0.04	0.13	0.23
Jul 29, 2026	0.05	0.15	0.24
Jul 28, 2026	0.06	0.16	0.26
Jul 27, 2026	0.09	0.19	0.29

MTNB shares rose +40.39% in Monday, July 27, 2026's trading session, rising from a previous close of $0.24 to move at $0.34. The stock demonstrated notable intraday movement (see MTNB's key stats for a full breakdown), fluctuating between $0.31 and $0.43, a +38.26% trading range. While recent weeks have seen some volatility, MTNB has managed to secure a -3.12% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 195.56M shares changing hands, 174.84M more than the previous session. This amounted to $66.27M in total market activity.

Will MTNB Continue Its Downward Trend?

According to analyst ratings and projections for MTNB, Matinas BioPharma Holdings, Inc. shares are anticipated to decrease by -78.12%, potentially reaching $0.19 per share by August 7, 2026. Short-term technical indicators for MTNB currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 20 negative trading days within the past 30 sessions. Based on the MTNB stock forecast, now is not the best time to buy MTNB stock because its current trading price is +258.62% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MTNB covering social and institutional perspectives.

MTNB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into MTNB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.65% to 40.33%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 41.82%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.17%, maintains a neutral outlook for the long term. Insights into MTNB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Matinas BioPharma Short-Term Forecasts

MTNB Forecast For Next 5 Days

Our algorithm anticipates Matinas BioPharma (MTNB) stock could hit $0.21 by Aug 03, 2026. This represents a -37.50% fall from today's price, following a -1.94% change over the past five days.

MTNB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Matinas BioPharma Holdings, Inc. (MTNB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.17, which would mean a -49.84% decrease from the current price of $0.34. Projections for this period range from a high of $0.43 to a low of $0.00.

MTNB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Matinas BioPharma's price over the next three months point to a drop. MTNB stock is expected to peak at $0.87 on Aug 31, 2026 before potentially dipping to $0.00 on Oct 27, 2026. On average, MTNB is likely to trade around $0.25 in the coming 90 days.

Matinas BioPharma Stock Forecast 2025

Based on our predictive models, Matinas BioPharma (MTNB) is expected to trade between $0.00 and $0.93 throughout 2026. This would result in an average price of $0.26, potentially offering investors a -23.28% return from current levels.

Matinas BioPharma Holdings, Inc. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, Matinas BioPharma Holdings, Inc. (MTNB) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $0.80, settling at an average of $0.35. This could translate to a +3.28% gain.

August 2026

Based on current market signals, Matinas BioPharma Holdings, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $0.87, with a likely average price of $0.32. Investors could expect a potential return of -5.58%.

September 2026

Our predictive algorithms indicate Matinas BioPharma Holdings, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$0.82, with an average target of $0.20. This represents a cautious outlook and a possible loss of -40.99%.

October 2026

Analyzing established trends, Matinas BioPharma Holdings, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $0.83, averaging around $0.20. This suggests a -40.99% loss from current levels.

November 2026

Market indicators suggest Matinas BioPharma Holdings, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $0.93, with a midpoint forecast of $0.36. The stock might deliver a +6.23% gain.

December 2026

Forecasting for December 2026, models estimate that Matinas BioPharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.72, averaging $0.20. This signals a cautious trajectory with potential returns around -40.99%.

January 2027

According to our latest forecast models, Matinas BioPharma Holdings, Inc. (MTNB) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $0.91, settling at an average of $0.35. This could translate to a +3.28% gain.

February 2027

Based on current market signals, Matinas BioPharma Holdings, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $0.86, with a likely average price of $0.33. Investors could expect a potential return of -2.63%.

March 2027

Our predictive algorithms indicate Matinas BioPharma Holdings, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$0.85, with an average target of $0.29. This represents a cautious outlook and a possible loss of -14.43%.

April 2027

Analyzing established trends, Matinas BioPharma Holdings, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $0.84, averaging around $0.29. This suggests a -14.43% loss from current levels.

May 2027

Market indicators suggest Matinas BioPharma Holdings, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $0.66, with a midpoint forecast of $0.10. The stock might deliver a -70.49% loss.

June 2027

Forecasting for June 2027, models estimate that Matinas BioPharma Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.66, averaging $0.20. This signals a cautious trajectory with potential returns around -40.99%.

July 2027

According to our latest forecast models, Matinas BioPharma Holdings, Inc. (MTNB) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $0.56, settling at an average of $0.22. This could translate to a -35.08% loss.

MTNB's history of dividends and stock splits also plays a role in long-term investor confidence.